216 related articles for article (PubMed ID: 32351215)
21. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727
[TBL] [Abstract][Full Text] [Related]
22. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.
Joel DD; Coderre JA; Micca PL; Nawrocky MM
J Neurooncol; 1999 Feb; 41(3):213-21. PubMed ID: 10359141
[TBL] [Abstract][Full Text] [Related]
23. Boron neutron capture therapy for malignant tumors related to meningiomas.
Miyatake S; Tamura Y; Kawabata S; Iida K; Kuroiwa T; Ono K
Neurosurgery; 2007 Jul; 61(1):82-90; discussion 90-1. PubMed ID: 17621022
[TBL] [Abstract][Full Text] [Related]
24. Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor.
Wang LW; Liu YH; Chou FI; Jiang SH
Cancer Commun (Lond); 2018 Jun; 38(1):37. PubMed ID: 29914577
[TBL] [Abstract][Full Text] [Related]
25. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
[TBL] [Abstract][Full Text] [Related]
26. Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound.
Alkins RD; Brodersen PM; Sodhi RN; Hynynen K
Neuro Oncol; 2013 Sep; 15(9):1225-35. PubMed ID: 23640533
[TBL] [Abstract][Full Text] [Related]
27. Boron Neutron Capture Therapy for Malignant Brain Tumors.
Miyatake S; Kawabata S; Hiramatsu R; Kuroiwa T; Suzuki M; Kondo N; Ono K
Neurol Med Chir (Tokyo); 2016 Jul; 56(7):361-71. PubMed ID: 27250576
[TBL] [Abstract][Full Text] [Related]
28. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
[TBL] [Abstract][Full Text] [Related]
29. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography.
Nichols TL; Kabalka GW; Miller LF; Khan MK; Smith GT
Med Phys; 2002 Oct; 29(10):2351-8. PubMed ID: 12408309
[TBL] [Abstract][Full Text] [Related]
30. Monte Carlo-based treatment planning for boron neutron capture therapy using custom designed models automatically generated from CT data.
Zamenhof R; Redmond E; Solares G; Katz D; Riley K; Kiger S; Harling O
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):383-97. PubMed ID: 8635948
[TBL] [Abstract][Full Text] [Related]
31. Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden.
Capala J; Stenstam BH; Sköld K; Munck af Rosenschöld P; Giusti V; Persson C; Wallin E; Brun A; Franzen L; Carlsson J; Salford L; Ceberg C; Persson B; Pellettieri L; Henriksson R
J Neurooncol; 2003; 62(1-2):135-44. PubMed ID: 12749709
[TBL] [Abstract][Full Text] [Related]
32. Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential.
Hopewell JW; Gorlia T; Pellettieri L; Giusti V; H-Stenstam B; Sköld K
Appl Radiat Isot; 2011 Dec; 69(12):1737-40. PubMed ID: 21482122
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
34. [Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors].
Kanygin VV; Kichigin AI; Gubanova NV; Taskaev SY
Vestn Rentgenol Radiol; 2015; (6):36-42. PubMed ID: 26999933
[TBL] [Abstract][Full Text] [Related]
35. Strategic planning workshop on research needs for neutron capture therapy.
Feinendegen LE
J Neurooncol; 1997 May; 33(1-2):179-85. PubMed ID: 9151235
[TBL] [Abstract][Full Text] [Related]
36. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
37. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
Haritz D; Gabel D; Huiskamp R
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1175-81. PubMed ID: 8175403
[TBL] [Abstract][Full Text] [Related]
38. The early successful treatment of glioblastoma patients with modified boron neutron capture therapy. Report of two cases.
Kawabata S; Miyatake S; Kajimoto Y; Kuroda Y; Kuroiwa T; Imahori Y; Kirihata M; Sakurai Y; Kobayashi T; Ono K
J Neurooncol; 2003 Nov; 65(2):159-65. PubMed ID: 14686736
[TBL] [Abstract][Full Text] [Related]
39. The rationale and requirements for the development of boron neutron capture therapy of brain tumors.
Soloway AH; Barth RF; Gahbauer RA; Blue TE; Goodman JH
J Neurooncol; 1997 May; 33(1-2):9-18. PubMed ID: 9151219
[TBL] [Abstract][Full Text] [Related]
40. Boron neutron capture enhancement of fast neutron for nonremoved glioblastomas: rationale of a clinical trial. EORTC BNCT Study Group.
Pignol JP; Paquis P; Breteau N; Chauvel P; Sauerwein W
Front Radiat Ther Oncol; 1999; 33():43-50. PubMed ID: 10549475
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
